Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sodium DL-3-hydroxybutyrate
Special Order
Sodium DL-3-hydroxybutyrate
Powder
No Controlled Drug Status
Valid as a prescribable product
BNF: